Seminars 2002-2003

2002-2003 SEMINAR SCHEDULE

DATE	SEMINAR SPEAKER	SEMINAR TITLE
9/26/02	Dennis Dickson, MD Professor Dept. of Pathology Mayo Clinic - Jacksonville	“4R Tauopathies”
10/24/02	Mark Forman, MD, PhD Research Associate Dept of Pathology and Lab Medicine Univ of Pennsylvania	"Mechanisms of brain degeneration in tauopathies"
11/21/02	Angela R. Cantrell, PhD Assistant Professor Department of Anatomy and Neurobiology University of Tennessee Health Science Center	"Examining Alterations in Ion Channel Activity as a Potential Mechanism Underlying Neuronal Dysfunction in Neurodegenerative Disease"
1/8/03	Benoit Giasson, PhD University of Pennsylvania Departments of Pathology and Laboratory Medicine	“Molecular Neuropathology of Synucleinopathies”
1/14/03	David Munoz, MD, FRCPC Department of Neurology Hospital Ruber International Madrid, Spain	“Alzheimer's Disease: Role of environmental factors with a focus on education and anti-inflammatory drug use”
1/21/03	David R. Borchelt, PhD Associate Professor Departments of Pathology and Neuroscience The John Hopkins University School of Medicine	"Mutatuins Associated with Familial Neurodegenerative Diseases Induced Protein Misfolding and/or Aggregation"
1/23/03	Jeffrey H.Kordower,PhD Professor Dept. of Neurological Sciences Rush Presbyterian Medical Center	"Gene Therapy for Neurodegenerative Diseases"
2/5/03	Kate Cherry, MBBS, FRACP Alfred Hospital, Melbourne, Australia	"Nucleosides and HIB - Combined Effect on Mitochondria and the Pathogenesis of Neuropathy"
2/27/03	David Holtzman,MD Professor Dept. of Neurology Washington University	“Role of endogenous and exogenous amyloid-beta binding molecules in thepathogenesis, diagnosis, and treatment of Alzheimer's disease”
3/27/03	Bob Gracy, PhD Associate Vice President Research and Biotechnology University of North Texas	"Aging, Apoptosis, Alzheimers, and Antioxidants"
4/24/03	Jeffrey Rothstein, MD, PhD Professor Dept. of Neurology and Neuroscience Johns Hopkins University	“Dysregulation of synaptic transporters - a pathway towards neurodegeneration andtherapy”

Center for Neurodegerative Disease
Emory University

Direct comments and questions to: CND@emory.edu
404-727-3727